European equities traded in the US as American depositary receipts were lower on Friday morning, down 0.3% to 1,457.10 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company Evaxion (EVAX) and pharmaceutical company Grifols (GRFS), which rose 5.5% and 1.6% respectively.
They were followed by energy company Eni (E), which was adding 1%.
The decliners from continental Europe were led by pharmaceutical research company Galapagos (GLPG) and biopharmaceutical firm DBV Technologies (DBVT), which fell 3.4% and 2.9% respectively.
They were followed by semiconductor company ASML (ASML), which was down 2.4%.
From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and telecom provider Vodafone (VOD), which rose 2% and 1.5% respectively.
The decliners from the UK and Ireland were led by pharmaceutical companies Compass Pathways (CMPS) and Centessa Pharmaceuticals (CNTA), which declined 5.8% and 2.8% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.